Literature DB >> 7682550

Endothelial nitric oxide synthase. N-terminal myristoylation determines subcellular localization.

L Busconi1, T Michel.   

Abstract

Nitric oxide synthases in diverse mammalian tissues catalyze the oxidation of L-arginine to L-citrulline plus nitric oxide (NO). In the vascular endothelium, synthesis of NO yields a labile intercellular messenger molecule with potent biological activities, including vascular smooth muscle relaxation. We have recently documented that the endothelial cell NO synthase (EC-NOS) constitutes a genetically distinct tissue-specific enzyme isoform. In further contrast to the soluble NO synthases found in neural tissues and in macrophages, the endothelial enzyme is associated primarily with the particulate fraction. Analysis of molecular clones for the endothelial NO synthase reveals no obvious transmembrane-spanning region, but a consensus motif for N-terminal myristoylation was identified; such a consensus sequence is not evident in the primary sequence of the soluble macrophage and neural NO synthases. We performed oligonucleotide-directed mutagenesis of the myristoylation consensus sequence in the endothelial NO synthase cDNA, and studied the pattern of expression of the wild-type and mutant EC-NOS cDNAs in transient transfection experiments in COS-7 cells. The subcellular localization of heterologous endothelial NO synthase was determined using analyses of enzyme activity as well as immunoprecipitation of biosynthetically labeled NO synthase with a highly specific antipeptide antibody. Expression of the wild-type endothelial NO synthase cDNA in COS-7 cells results in targeting of both enzyme activity and NO synthase immunoreactivity primarily to the particular fraction. By contrast, transient expression of the myristoylation- mutant cDNA in COS-7 cells yields NO synthase enzyme activity and immunoreactivity associated exclusively with the cytosol fraction. Following biosynthetic labeling with [3H]myristate, the NO synthase can be specifically immunoprecipitated from the particulate fraction in endothelial and in COS-7 cells transfected with the wild-type cDNA, but not in cells transfected with the myristoylation- mutant EC-NOS cDNA. N-terminal myristoylation of the endothelial NO synthase may provide a potential point of regulation of the biological functions of endothelium-derived NO in situ.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682550

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

Review 1.  Endothelial nitric oxide in humans in health and disease.

Authors:  P Vallance; A Hingorani
Journal:  Int J Exp Pathol       Date:  1999-12       Impact factor: 1.925

Review 2.  Molecular mechanisms of estrogen actions on the vasculature.

Authors:  M P Haynes; K S Russell; J R Bender
Journal:  J Nucl Cardiol       Date:  2000 Sep-Oct       Impact factor: 5.952

3.  There's NO binding like NOS binding: protein-protein interactions in NO/cGMP signaling.

Authors:  Pavel I Nedvetsky; William C Sessa; Harald H H W Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-16       Impact factor: 11.205

4.  ACh-induced endothelial NO synthase translocation, NO release and vasodilatation in the hamster microcirculation in vivo.

Authors:  Xavier F Figueroa; Daniel R González; Agustín D Martínez; Walter N Durán; Mauricio P Boric
Journal:  J Physiol       Date:  2002-11-01       Impact factor: 5.182

Review 5.  PPARgamma as a potential therapeutic target in pulmonary hypertension.

Authors:  Roy L Sutliff; Bum-Yong Kang; C Michael Hart
Journal:  Ther Adv Respir Dis       Date:  2010-06       Impact factor: 4.031

6.  Nitric oxide signaling participates in norepinephrine-induced activity of neuronal intracellular survival pathways.

Authors:  Michael J Chen; Amelia A Russo-Neustadt
Journal:  Life Sci       Date:  2007-09-15       Impact factor: 5.037

Review 7.  Sphingosine-1-phosphate and modulation of vascular tone.

Authors:  Junsuke Igarashi; Thomas Michel
Journal:  Cardiovasc Res       Date:  2009-02-20       Impact factor: 10.787

Review 8.  Endothelial nitric oxide synthase and endothelial dysfunction.

Authors:  Paul L Huang
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

9.  Coordinated endothelial nitric oxide synthase activation by translocation and phosphorylation determines flow-induced nitric oxide production in resistance vessels.

Authors:  Xavier F Figueroa; Daniel R González; Mariela Puebla; Juan P Acevedo; Daniel Rojas-Libano; Walter N Durán; Mauricio P Boric
Journal:  J Vasc Res       Date:  2013-11-05       Impact factor: 1.934

10.  ADP signaling in vascular endothelial cells: ADP-dependent activation of the endothelial isoform of nitric-oxide synthase requires the expression but not the kinase activity of AMP-activated protein kinase.

Authors:  Connie Ng Hess; Ruqin Kou; Rosalyn P Johnson; Gordon K Li; Thomas Michel
Journal:  J Biol Chem       Date:  2009-09-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.